Phathom Pharmaceuticals initiated at Market Perform; PT set at $10
Leerink Partners initiated Phathom Pharmaceuticals with a Market Perform rating and announced a $10.00 per-share price target, per TradingView News via Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.